Delhi HC upholds Bristol Myers' patent for anti-cancer drug Dasatinib, imposes Rs 5L penalty on SP Labs Farhat Nasim9 Nov 2024 5:40 PM ISTNew Delhi: In relief to Bristol-Myers Squibb Holdings Ireland (BMS), the Delhi High Court has upheld its patent for the anti-cancer drug dasatinib and...
From Cancer Medicines to Insulins: AIIMS Expands Free Medication List Kajal Rajput20 Oct 2023 1:40 PM ISTAIIMS Delhi has expanded its list of free medications by adding 63 more drugs, bringing the total to 359. This move aims to enhance healthcare...
Cancer drug Dasatinib also lowers blood glucose, finds retrospective study Hina Zahid9 Dec 2021 9:00 AM ISTROCHESTER, Minnesota - Dasatinib, a drug that often is used to treat certain types of leukemia, may have antidiabetic effects comparable to...
Dasatinib a novel diabetic therapy for control of blood sugar and weight: Study Medha Baranwal1 Dec 2021 9:00 AM ISTUSA: Treatment of type 2 diabetes (T2D) patients with dasatinib for a year led to a greater reduction in body weight and blood sugar versus those...
Shilpa Medicare launches generic verision cancer drug Dasatinib at monthly therapy cost of Rs 6,440 Ruchika Sharma25 April 2020 12:44 PM ISTThe branded generic anti-cancer drug will be available in all dosage strengths of 20/ 50/ 70/ 100 mg tablets
Dr Reddy's Labs launches Invista(dasatinib) in India Medical Dialogues Bureau15 April 2020 12:30 PM ISTHyderabad: Dr. Reddy's Laboratories Ltd., has announced the launch of Invista®, a formulation of Dasatinib that is bioequivalent to the innovator...
Commerce and Industry Ministry considering proposal for compulsory license to anti-cancer drug Meghna A Singhania26 July 2015 1:43 AM ISTNEW DELHI: Commerce and Industry Ministry is considering a proposal of the health ministry for grant of compulsory license (CL) to an anti-cancer drug...
